Navigation path

HOME
Policy areas
Sectors
Who is in charge?
Competition and you
Cases
In this section:
Overview
What's new?
Official Journal
Legislation >
Cases
Statistics
Publications (Antitrust and Cartels)
Leniency
Whistleblower
Settlement
Compliance (Antitrust)
Practical information (Antitrust and Cartels)

Antitrust/Cartels

Antitrust/Cartel Cases

39226 Lundbeck

Companies: A.L. Industrier / Arrow Generics Limited / Arrow Group ApS / Generics UK Ltd / Lundbeck / Merck / Ranbaxy (UK) / Ranbaxy Laboratories / Resolution Chemicals / Xellia Pharmaceuticals ApS / Zoetis Products LLC
Economic Activity: C.21.1 - Manufacture of basic pharmaceutical products
G.46.46 - Wholesale of pharmaceutical goods
Events:
Date Document Type Document
08.09.2016 Press Release Antitrust: Commission welcomes General Court judgments upholding its Lundbeck decision in first pharma pay-for-delay case:
en
07.03.2015 Report of the Hearing Officer Final Report of the Hearing Officer:
Multilingual
07.03.2015 Opinion of the Advisory Committee First Advisory Committee:
Multilingual
19.06.2013 Summary Decision Summary of the Decision:
Multilingual
19.06.2013 Prohibition Decision (Art. 101 Ex 81) en pdf  Published on 19.01.2015
19.06.2013 Press Release Commission fines Lundbeck and other pharma companies for delaying market entry of generic medicines:
Multilingual
17.06.2013 Opinion of the Advisory Committee Second Advisory Committee:
Multilingual
25.07.2012 Press Release Antitrust: Commission sends Statement of Objections to Lundbeck and others for preventing market entry of generic antidepressant medicine:
en
07.01.2010 Opening of Proceedings en pdf
These publications are for information purposes only and should not be considered as an official publication

New Search

Help on how to use the case search tool